ABEO — Abeona Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Abeona Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	95	45	52.1	52.2	97.7
Net Total Accounts Receivable
Net Total Receivables	—	3	0.188	2.44	1.65
Prepaid Expenses
Total Other Current Assets
Total Current Assets	97.7	55.4	53.1	55.7	101
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18.4	21.7	11.1	7.99	7.98
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	151	79.6	64.2	64	109
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	42	16.6	7.78	13.4	16.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	48.6	28.2	37.5	49.2	64.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	103	51.4	26.8	14.8	44
Total Liabilities & Shareholders' Equity	151	79.6	64.2	64	109
Total Common Shares Outstanding
Total Preferred Shares Outstanding